4-(1-Phenylethyl)resorcinol

CAS No. 85-27-8

4-(1-Phenylethyl)resorcinol( —— )

Catalog No. M35892 CAS No. 85-27-8

4-(1-Phenylethyl)resorcinol (4-(1-Phenylethyl)benzene-1,3-diol) is a skin brightening agent that is a cosmetic additive.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 26 In Stock

Biological Information

  • Product Name
    4-(1-Phenylethyl)resorcinol
  • Note
    Research use only, not for human use.
  • Brief Description
    4-(1-Phenylethyl)resorcinol (4-(1-Phenylethyl)benzene-1,3-diol) is a skin brightening agent that is a cosmetic additive.
  • Description
    4-(1-Phenylethyl)resorcinol is a skin lightening agent used in cosmetics. It works by inhibiting the production of melanin, the pigment that gives skin its color. This helps reduce the appearance of dark spots, hyperpigmentation and uneven skin tone. 4-(1-Phenylethyl)resorcinol is considered safe for cosmetic use and is approved for use in several countries.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    85-27-8
  • Formula Weight
    214.26
  • Molecular Formula
    C14H14O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (466.72 mM; Ultrasonic )
  • SMILES
    CC(c1ccccc1)c1ccc(O)cc1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (D-2-Nal5,Cys6·11,Ty...

    BIM 23042, a certain somatostatin (SS) octapeptide analogue, is a selective neuropeptide neuromedin B receptor (NMB-R, BB1) antagonist. BIM 23042 has 100-fold lower affinity for gastrin-releasing peptide (GRP) receptor (BB2). BIM 23042 inhibits Neuromedin?B?, ICI 216140 and DPDM-bombesin ethylamide-induced Ca2+ release.

  • hPL-IN-2

    hPL-IN-2 is a potent, reversible and non-competitive inhibitor of Pancreatic lipase (IC50: 1.63 μM) that can be used to investigate obesity-related diseases.

  • Magainin 1 TFA (1084...

    Magainin 1 TFA is an antimicrobial amphiphilic peptide isolated from xenopus skin.